IEFM
REGN icon

IQ EQ Fund Management’s Regeneron Pharmaceuticals REGN Stock Holding History

IQ EQ Fund Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-515
Closed -$290K – 323
2025
Q3 		$290K Buy
+515
New +$291K 0.02% 286
2021
Q4 		– Sell
-546
Closed -$330K – 255
2021
Q3 		$330K Hold
546
– – 0.05% 218
2021
Q2 		$305K Hold
546
– – 0.05% 226
2021
Q1 		$258K Hold
546
– – 0.05% 235
2020
Q4 		$264K Hold
546
– – 0.06% 205
2020
Q3 		$306K Hold
546
– – 0.09% 163
2020
Q2 		$341K Buy
+546
New +$310K 0.11% 128

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

IQ EQ Fund Management's REGN Position: Q4 2025 in Review

IQ EQ Fund Management sold out of Regeneron Pharmaceuticals (REGN) in Q4 2025, closing a stake of 515 shares — an estimated $290K sold.

IQ EQ Fund Management first reported a position in REGN in Q2 2020 and held it in 7 quarters. The position peaked at $341K in Q2 2020. 1,388 funds tracked by Wall St. Rank hold REGN as of Q4 2025.

  • IQ EQ Fund Management reported no remaining Regeneron Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • IQ EQ Fund Management sold 515 Regeneron Pharmaceuticals shares in Q4 2025, an estimated $290K.
  • IQ EQ Fund Management first reported a position in Regeneron Pharmaceuticals in Q2 2020 and held it in 7 quarters.
  • IQ EQ Fund Management's Regeneron Pharmaceuticals position peaked at $341K in Q2 2020.
  • 1,388 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2025.

Based on IQ EQ Fund Management's 13F filing for Q4 2025, filed 12 Feb 2026.